ae37 + gm-csf vaccine
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2007 (NCT00524277)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ae37 + gm-csf vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00524277 | Phase 2 | Jan 1, 2007 | Generex Biotechnology Corp., Norwell, Inc., United States Army, University of Texas at Houston |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Generex Biotechnology Corp. | For profit | 1 | 0 | 1 | 2007 |
| Norwell, Inc. | For profit | 1 | 0 | 1 | 2007 |
| United States Army | Government | 1 | 1 | 1 | 2007 |
| University of Texas at Houston | Academic/Hospital | 1 | 0 | 1 | 2007 |
4 organizations
Page 1 / 1